Financhill
Sell
47

MCBS Quote, Financials, Valuation and Earnings

Last price:
$26.25
Seasonality move :
-4.81%
Day range:
$26.36 - $26.67
52-week range:
$24.24 - $34.91
Dividend yield:
3.62%
P/E ratio:
10.25x
P/S ratio:
2.88x
P/B ratio:
1.52x
Volume:
53.2K
Avg. volume:
53.9K
1-year change:
-16.93%
Market cap:
$677.8M
Revenue:
$235.9M
EPS (TTM):
$2.59

Analysts' Opinion

  • Consensus Rating
    MetroCity Bankshares, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $31.00, MetroCity Bankshares, Inc. has an estimated upside of 16.81% from its current price of $26.54.
  • Price Target Downside
    According to analysts, the lowest downside price target is $31.00 representing 100% downside risk from its current price of $26.54.

Fair Value

  • According to the consensus of 1 analyst, MetroCity Bankshares, Inc. has 16.81% upside to fair value with a price target of $31.00 per share.

MCBS vs. S&P 500

  • Over the past 5 trading days, MetroCity Bankshares, Inc. has underperformed the S&P 500 by -0.64% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • MetroCity Bankshares, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • MetroCity Bankshares, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter MetroCity Bankshares, Inc. reported revenues of $60.1M.

Earnings Growth

  • MetroCity Bankshares, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter MetroCity Bankshares, Inc. reported earnings per share of $0.67.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
2.88x
EV / EBIT:
6.20x
EV / Revenue:
4.68x
PEG ratio (5yr expected):
0.92x
EV / Free cash flow:
22.00x
Price / Operating cash flow:
13.52x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.84%
Net Income Margin (TTM):
28.06%
Return On Equity:
15.58%
Return On Invested Capital:
7.93%
Operating Margin:
39.69%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $201.6M $232.9M $237.4M $60.2M $60.1M
Gross Profit -- -- -- -- --
Operating Income $75.4M $82.6M $92.1M $22.7M $23.8M
EBITDA -- -- -- -- --
Diluted EPS $2.10 $2.33 $2.59 $0.65 $0.67
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $268.4M $195.8M $297.4M $308.4M $245M
Total Assets $2.8B $3.3B $3.5B $3.6B $3.6B
Current Liabilities $642.5M $605.8M $565.4M $558M $550.1M
Total Liabilities $2.5B $3B $3.1B $3.2B $3.2B
Total Equity $276.2M $349M $384.7M $407.2M $445.9M
Total Debt $308.7M $382.7M $330.6M $380.4M $430.6M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $78.2M $38.4M $51.3M -$8M $15.9M
Cash From Investing -$50.1M -$63.3M -$110.7M -$787K -$71.4M
Cash From Financing $74.3M $34.1M -$4.7M -$27.9M -$3.3M
Free Cash Flow $73.3M $36.5M $50.5M -$8.3M $15.6M
MCBS
Sector
Market Cap
$677.8M
$554M
Price % of 52-Week High
76.02%
90.96%
Dividend Yield
3.62%
1.58%
Shareholder Yield
1.86%
3.08%
1-Year Price Total Return
-16.93%
6.77%
Beta (5-Year)
0.720
0.463
Dividend yield:
3.62%
Annualized payout:
$0.83
Payout ratio:
37.36%
Growth streak:
4 years

Technicals

8-day SMA
Sell
Level $27.05
200-day SMA
Sell
Level $27.80
Bollinger Bands (100)
Sell
Level 26.11 - 28.97
Chaikin Money Flow
Buy
Level 6.7M
20-day SMA
Sell
Level $27.60
Relative Strength Index (RSI14)
Sell
Level 40.76
ADX Line
Sell
Level 18.98
Williams %R
Buy
Level -93.4058
50-day SMA
Sell
Level $26.66
MACD (12, 26)
Sell
Level 0.01
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 5.8M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.0046)
Sell
CA Score (Annual)
Level (-1.9847)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.4109)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

MetroCity Bankshares, Inc. is a bank holding company, which engages in the provision of commercial bank services. The firm offers customary banking services as consumer and commercial checking accounts, savings accounts, certificates of deposit, commercial and consumer loans, single family residential loans, and money transfers services. Its portfolio includes construction and development, commercial real estate, commercial and industrial, single family residential mortgages, and consumer and other. The company was founded in 2014 and is headquartered in Doraville, GA.

Stock Forecast FAQ

In the current month, MCBS has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The MCBS average analyst price target in the past 3 months is $31.00.

  • Where Will MetroCity Bankshares, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that MetroCity Bankshares, Inc. share price will rise to $31.00 per share over the next 12 months.

  • What Do Analysts Say About MetroCity Bankshares, Inc.?

    Analysts are divided on their view about MetroCity Bankshares, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MetroCity Bankshares, Inc. is a Sell and believe this share price will drop from its current level to $31.00.

  • What Is MetroCity Bankshares, Inc.'s Price Target?

    The price target for MetroCity Bankshares, Inc. over the next 1-year time period is forecast to be $31.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is MCBS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for MetroCity Bankshares, Inc. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.

  • How Can I Buy Shares Of MCBS?

    You can purchase shares of MetroCity Bankshares, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MetroCity Bankshares, Inc. shares.

  • What Is The MetroCity Bankshares, Inc. Share Price Today?

    MetroCity Bankshares, Inc. was last trading at $26.25 per share. This represents the most recent stock quote for MetroCity Bankshares, Inc.. Yesterday, MetroCity Bankshares, Inc. closed at $26.54 per share.

  • How To Buy MetroCity Bankshares, Inc. Stock Online?

    In order to purchase MetroCity Bankshares, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.74% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 9.71% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock